WO2024023654 - AN INHALER COMPRISING A RETENTION ELEMENT
National phase entry:
Publication Number
WO/2024/023654
Publication Date
01.02.2024
International Application No.
PCT/IB2023/057365
International Filing Date
19.07.2023
Title **
[English]
AN INHALER COMPRISING A RETENTION ELEMENT
[French]
INHALATEUR COMPRENANT UN ÉLÉMENT DE RETENUE
Applicants **
VECTURA INC.
Inventors
SWANBURY, Philip John
YADIDI, Kambiz
AYDIN, Mo
Priority Data
22187663.4
28.07.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2030 | |
| EPO | Filing, Examination, Granting | 8133 | |
| Japan | Filing, Examination, Granting | 2178 | |
| South Korea | Filing, Examination, Granting | 2043 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,124
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
There is provided an inhaler (200) comprising a housing defining an inlet (111), an outlet (113), and an airflow path extending from the inlet (111) to the outlet (113). The inhaler (200) comprises a capsule receptacle (221) for receiving a capsule (230) comprising a composition for inhalation. The inhaler (200) comprises a rupturing element (140) for rupturing the capsule (230) received in the capsule receptacle (221). The inhaler (200) comprises an aerosolization chamber (222) for allowing the composition to be entrained in airflow within the airflow path. The inhaler (200) comprises a retention element (250) movable between a first position in which the capsule (230) is prevented from moving from the capsule receptacle (221) to the aerosolization chamber (222), and a second position in which the capsule (230) is movable from the capsule receptacle (221) to the aerosolization chamber (222). There is also provided a composition that is administered to a patient using the inhaler (200).[French]
L'invention concerne un inhalateur (200) comprenant un boîtier définissant une entrée (111), une sortie (113) et un trajet d'écoulement d'air s'étendant de l'entrée (111) à la sortie (113). L'inhalateur (200) comprend un réceptacle de capsule (221) pour recevoir une capsule (230) comprenant une composition pour inhalation. L'inhalateur (200) comprend un élément de rupture (140) pour rompre la capsule (230) reçue dans le réceptacle de capsule (221). L'inhalateur (200) comprend une chambre d'aérosolisation (222) pour permettre à la composition d'être entraînée dans un écoulement d'air à l'intérieur du trajet d'écoulement d'air. L'inhalateur (200) comprend un élément de retenue (250) mobile entre une première position dans laquelle la capsule (230) est empêchée de se déplacer du réceptacle de capsule (221) à la chambre d'aérosolisation (222), et une seconde position dans laquelle la capsule (230) est mobile du réceptacle de capsule (221) à la chambre d'aérosolisation (222). L'invention concerne également une composition qui est administrée à un patient à l'aide de l'inhalateur (200).